YM

Yagneshkumar Manjibhai Baraiya

Active Director Director DIN 10263144
DIN 10263144 First appointment Aug 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Yagneshkumar Manjibhai Baraiya

Data last updated:

Yagneshkumar Manjibhai Baraiya is a Director at Homeohub Healthcare Private Limited (since 2023).

DIN 10263144
Primary Designation Director
First Appointment 01 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Homeohub Healthcare Private Limited U86100GJ2023PTC143501
Director01 Aug 20232023Active

Board colleagues of Yagneshkumar Manjibhai Baraiya

NameDINCompanyDesignation
Krupa Labhubhai Jinjariya10263145Homeohub Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Homeohub Healthcare Private Limited
Premium access

Shareholding and investment profile for Yagneshkumar Manjibhai Baraiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yagneshkumar Manjibhai Baraiya

Yagneshkumar Manjibhai Baraiya currently holds 1 directorship: Homeohub Healthcare Private Limited (Director, since 01 Aug 2023).

Yagneshkumar Manjibhai Baraiya was first appointed on 01 Aug 2023 as Director at Homeohub Healthcare Private Limited.

The current boards of Yagneshkumar Manjibhai Baraiya's companies include Krupa Labhubhai Jinjariya (Homeohub Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available